Literature DB >> 23237696

OPTN/SRTR 2011 Annual Data Report: pancreas.

R Kandaswamy1, P G Stock, M A Skeans, S K Gustafson, E F Sleeman, J L Wainright, R J Carrico, V Ghimire, J J Snyder, A K Israni, B L Kasiske.   

Abstract

Numbers of pancreas transplants have been decreasing over the past decade, but outcomes continue to improve for all types: simultaneous pancreas-kidney transplant, pancreas after kidney transplant (PAK), and pancreas transplant alone (PTA). The most notable decrease occurred for PAK transplants, possibly due in part to decreases in numbers of living donor kidney transplants. The number of new candidates on the pancreas transplant waiting list has decreased steadily since 2000; only 1005 active candidates were added in 2011. Transplant rates for all pancreas transplant types reached a low in 2011 of 34.9 transplants per 100 wait-list years. Deceased donation rates have also been decreasing since 2005, but use of donation after circulatory death has been gradually increasing. The discard rate in 2011 was 27.7%, and higher for pancreata recovered from older donors. Improved outcomes during the early posttransplant period largely reflect improved donor and recipient selection and improved technical strategies. Inconsistent definitions of graft failure across reporting centers creates an ongoing challenge in the interpretation of outcome data for pancreas transplants. Rates of posttransplant re-hospitalization are high, most occurring in the first 6 months. Rejection rates are highest for PTA recipients, who also experience higher incidence of posttransplant lymphoproliferative disorder. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23237696     DOI: 10.1111/ajt.12020

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.

Authors:  Adam L Burrack; Laurie G Landry; Janet Siebert; Marilyne Coulombe; Ronald G Gill; Maki Nakayama
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

2.  Isolated pancreas rejections do not have an adverse impact on kidney graft survival whereas kidney rejections are associated with adverse pancreas graft survival in simultaneous pancreas kidney transplantation.

Authors:  Irfan Moinuddin; Muhammad Sohail Yaqub; Tim Taber; John Powelson; Jonathan Fridell; Asif Sharfuddin
Journal:  J Nephrol       Date:  2017-09-16       Impact factor: 3.902

Review 3.  Pancreas transplantation: solid organ and islet.

Authors:  Shruti Mittal; Paul Johnson; Peter Friend
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

Review 4.  Solid organ transplantation in the 21st century.

Authors:  Cara K Black; Kareem M Termanini; Oswaldo Aguirre; Jason S Hawksworth; Michael Sosin
Journal:  Ann Transl Med       Date:  2018-10

5.  Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.

Authors:  Rebecca Hartzell Robinson; Joseph J Meissler; Jessica M Breslow-Deckman; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

6.  Use of Ex Vivo Normothermic Perfusion for Quality Assessment of Discarded Human Donor Pancreases.

Authors:  A D Barlow; M O Hamed; D H Mallon; R J Brais; F M Gribble; M A Scott; W J Howat; J A Bradley; E M Bolton; G J Pettigrew; S A Hosgood; M L Nicholson; K Saeb-Parsy
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

7.  Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.

Authors:  Brian C Eby; Robert R Redfield; Thomas M Ellis; Glen E Leverson; Abby R Schenian; Jon S Odorico
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

Review 8.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

Review 9.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

10.  Under Utilization of Pancreas Transplants in Cystic Fibrosis Recipients in the United Network Organ Sharing (UNOS) Data 1987-2014.

Authors:  D J Usatin; E R Perito; A M Posselt; P Rosenthal
Journal:  Am J Transplant       Date:  2016-02-15       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.